CovidChloroV1, Main, Corpus, bibRecord, 001800

Chloroquine: Can it be a Novel Drug for COVID-19.

Identifieur interne : 001800 ( Main/Corpus ); précédent : 001799; suivant : 001801

Chloroquine: Can it be a Novel Drug for COVID-19.

Auteurs : Dinesh Kumar Badyal ; Rajiv Mahajan

Source :

International journal of applied & basic medical research [ 2229-516X ]

RBID : pubmed:32363157

Abstract

Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19.

DOI: 10.4103/ijabmr.IJABMR_141_20
PubMed: 32363157
PubMed Central: PMC7189906

Links to Exploration step

pubmed:32363157

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Chloroquine: Can it be a Novel Drug for COVID-19.</title>
<author><name sortKey="Badyal, Dinesh Kumar" sort="Badyal, Dinesh Kumar" uniqKey="Badyal D" first="Dinesh Kumar" last="Badyal">Dinesh Kumar Badyal</name>
<affiliation><nlm:affiliation>Department of Pharmacology, CMCL-FAIMER Regional Institute, Christian Medical College, Ludhiana, Punjab, India.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Medical Education, CMCL-FAIMER Regional Institute, Christian Medical College, Ludhiana, Punjab, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mahajan, Rajiv" sort="Mahajan, Rajiv" uniqKey="Mahajan R" first="Rajiv" last="Mahajan">Rajiv Mahajan</name>
<affiliation><nlm:affiliation>Department of Pharmacology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020 Apr-Jun</date>
<idno type="RBID">pubmed:32363157</idno>
<idno type="pmid">32363157</idno>
<idno type="doi">10.4103/ijabmr.IJABMR_141_20</idno>
<idno type="pmc">PMC7189906</idno>
<idno type="wicri:Area/Main/Corpus">001800</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001800</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Chloroquine: Can it be a Novel Drug for COVID-19.</title>
<author><name sortKey="Badyal, Dinesh Kumar" sort="Badyal, Dinesh Kumar" uniqKey="Badyal D" first="Dinesh Kumar" last="Badyal">Dinesh Kumar Badyal</name>
<affiliation><nlm:affiliation>Department of Pharmacology, CMCL-FAIMER Regional Institute, Christian Medical College, Ludhiana, Punjab, India.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Medical Education, CMCL-FAIMER Regional Institute, Christian Medical College, Ludhiana, Punjab, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mahajan, Rajiv" sort="Mahajan, Rajiv" uniqKey="Mahajan R" first="Rajiv" last="Mahajan">Rajiv Mahajan</name>
<affiliation><nlm:affiliation>Department of Pharmacology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of applied & basic medical research</title>
<idno type="ISSN">2229-516X</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32363157</PMID>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2229-516X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>10</Volume>
<Issue>2</Issue>
<PubDate><MedlineDate>2020 Apr-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>International journal of applied & basic medical research</Title>
<ISOAbbreviation>Int J Appl Basic Med Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Chloroquine: Can it be a Novel Drug for COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>128-130</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/ijabmr.IJABMR_141_20</ELocationID>
<Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19.</AbstractText>
<CopyrightInformation>Copyright: © 2020 International Journal of Applied and Basic Medical Research.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Badyal</LastName>
<ForeName>Dinesh Kumar</ForeName>
<Initials>DK</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology, CMCL-FAIMER Regional Institute, Christian Medical College, Ludhiana, Punjab, India.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Medical Education, CMCL-FAIMER Regional Institute, Christian Medical College, Ludhiana, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mahajan</LastName>
<ForeName>Rajiv</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>India</Country>
<MedlineTA>Int J Appl Basic Med Res</MedlineTA>
<NlmUniqueID>101579831</NlmUniqueID>
<ISSNLinking>2229-516X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chloroquine</Keyword>
<Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">coronavirus disease 2019</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
</KeywordList>
<CoiStatement>There are no conflicts of interest.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>03</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>03</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>03</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32363157</ArticleId>
<ArticleId IdType="doi">10.4103/ijabmr.IJABMR_141_20</ArticleId>
<ArticleId IdType="pii">IJABMR-10-128</ArticleId>
<ArticleId IdType="pmc">PMC7189906</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
        <ReferenceList><Reference><Citation>Drugs Context. 2019 Nov 25;8:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31844421</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Indian J Pharmacol. 2020 Jan-Feb;52(1):1-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32201439</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2005 Aug 22;2:69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16115318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Crit Care. 2020 Mar 10;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32173110</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001800 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001800 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32363157
   |texte=   Chloroquine: Can it be a Novel Drug for COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32363157" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Chloroquine: Can it be a Novel Drug for COVID-19.

Chloroquine: Can it be a Novel Drug for COVID-19.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki